Division of General Internal Medicine, University of Pennsylvania, Philadelphia.
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
JAMA Intern Med. 2021 Apr 1;181(4):471-478. doi: 10.1001/jamainternmed.2020.8193.
It is unknown how much the mortality of patients with coronavirus disease 2019 (COVID-19) depends on the hospital that cares for them, and whether COVID-19 hospital mortality rates are improving.
To identify variation in COVID-19 mortality rates and how those rates have changed over the first months of the pandemic.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study assessed 38 517 adults who were admitted with COVID-19 to 955 US hospitals from January 1, 2020, to June 30, 2020, and a subset of 27 801 adults (72.2%) who were admitted to 398 of these hospitals that treated at least 10 patients with COVID-19 during 2 periods (January 1 to April 30, 2020, and May 1 to June 30, 2020).
Hospital characteristics, including size, the number of intensive care unit beds, academic and profit status, hospital setting, and regional characteristics, including COVID-19 case burden.
The primary outcome was the hospital's risk-standardized event rate (RSER) of 30-day in-hospital mortality or referral to hospice adjusted for patient-level characteristics, including demographic data, comorbidities, community or nursing facility admission source, and time since January 1, 2020. We examined whether hospital characteristics were associated with RSERs or their change over time.
The mean (SD) age among participants (18 888 men [49.0%]) was 70.2 (15.5) years. The mean (SD) hospital-level RSER for the 955 hospitals was 11.8% (2.5%). The mean RSER in the worst-performing quintile of hospitals was 15.65% compared with 9.06% in the best-performing quintile (absolute difference, 6.59 percentage points; 95% CI, 6.38%-6.80%; P < .001). Mean RSERs in all but 1 of the 398 hospitals improved; 376 (94%) improved by at least 25%. The overall mean (SD) RSER declined from 16.6% (4.0%) to 9.3% (2.1%). The absolute difference in rates of mortality or referral to hospice between the worst- and best-performing quintiles of hospitals decreased from 10.54 percentage points (95% CI, 10.03%-11.05%; P < .001) to 5.59 percentage points (95% CI, 5.33%-5.86%; P < .001). Higher county-level COVID-19 case rates were associated with worse RSERs, and case rate declines were associated with improvement in RSERs.
Over the first months of the pandemic, COVID-19 mortality rates in this cohort of US hospitals declined. Hospitals did better when the prevalence of COVID-19 in their surrounding communities was lower.
目前尚不清楚新冠肺炎(COVID-19)患者的死亡率在多大程度上取决于为其提供治疗的医院,以及 COVID-19 医院死亡率是否在改善。
确定 COVID-19 死亡率的变化情况,以及这些死亡率在大流行的最初几个月中是如何变化的。
设计、设置和参与者:本队列研究评估了 2020 年 1 月 1 日至 6 月 30 日期间,955 家美国医院收治的 38517 名成年 COVID-19 患者,以及其中 27801 名(72.2%)成年患者的一个子集,他们被收入了这 955 家医院中的 398 家,这些医院在 2 个时期(2020 年 1 月 1 日至 4 月 30 日和 5 月 1 日至 6 月 30 日)至少治疗了 10 名 COVID-19 患者。
医院特征,包括规模、重症监护室床位数量、学术和盈利状况、医院设置以及包括 COVID-19 病例负担在内的区域特征。
主要结局是 30 天院内死亡率或调整患者特征(包括人口统计学数据、合并症、社区或护理机构入院来源和自 2020 年 1 月 1 日以来的时间)后的风险标准化事件率(RSER)。我们研究了医院特征是否与 RSER 相关,或其随时间的变化。
参与者的平均(SD)年龄(18888 名男性[49.0%])为 70.2(15.5)岁。955 家医院的平均(SD)医院级 RSER 为 11.8%(2.5%)。在表现最差的五分之一的医院中,平均 RSER 为 15.65%,而表现最好的五分之一的医院为 9.06%(绝对差异,6.59 个百分点;95%CI,6.38%-6.80%;P < .001)。除了 1 家医院外,其余 398 家医院的平均 RSER 都有所提高;376 家(94%)提高了至少 25%。总体平均(SD)RSER 从 16.6%(4.0%)降至 9.3%(2.1%)。表现最差和最好的五分之一的医院之间的死亡率或转介到临终关怀的比率差异从 10.54 个百分点(95%CI,10.03%-11.05%;P < .001)降至 5.59 个百分点(95%CI,5.33%-5.86%;P < .001)。县一级的 COVID-19 病例率较高与较差的 RSER 相关,而病例率下降与 RSER 的改善相关。
在大流行的最初几个月中,本队列研究中美国医院的 COVID-19 死亡率有所下降。当社区内 COVID-19 的流行率较低时,医院的表现会更好。